Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors

    • Cancer
    • Solid Tumors
    • Metastatic Solid Tumors
    • Advanced Solid Tumors